LRRK2 and Parkinson disease: These variants are thought to influenceRAB29 gene expression levels (Gan-Or et al., 2012; Khalighet al., 2017; Sun et al., 2021), potentially modulating the activationof LRRK2 and thereby affecting lysosomal hydrolaseactivity in PD